Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 3
1981 3
1982 8
1983 1
1984 6
1985 4
1986 4
1987 6
1988 8
1989 8
1990 10
1991 6
1992 3
1993 3
1994 1
1995 6
1996 3
1997 5
1998 4
1999 8
2000 15
2001 13
2002 7
2003 9
2004 9
2005 25
2006 18
2007 15
2008 12
2009 11
2010 19
2011 8
2012 18
2013 12
2014 18
2015 13
2016 16
2017 12
2018 6
2019 6
2020 1
2021 4
2022 7
2023 4
2024 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

350 results

Results by year

Filters applied: . Clear all
Page 1
Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial.
Subbiah V, Kreitman RJ, Wainberg ZA, Gazzah A, Lassen U, Stein A, Wen PY, Dietrich S, de Jonge MJA, Blay JY, Italiano A, Yonemori K, Cho DC, de Vos FYFL, Moreau P, Fernandez EE, Schellens JHM, Zielinski CC, Redhu S, Boran A, Passos VQ, Ilankumaran P, Bang YJ. Subbiah V, et al. Among authors: zielinski cc. Nat Med. 2023 May;29(5):1103-1112. doi: 10.1038/s41591-023-02321-8. Epub 2023 Apr 14. Nat Med. 2023. PMID: 37059834 Free PMC article. Clinical Trial.
Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket study.
Subbiah V, Kreitman RJ, Wainberg ZA, Cho JY, Schellens JHM, Soria JC, Wen PY, Zielinski CC, Cabanillas ME, Boran A, Ilankumaran P, Burgess P, Romero Salas T, Keam B. Subbiah V, et al. Among authors: zielinski cc. Ann Oncol. 2022 Apr;33(4):406-415. doi: 10.1016/j.annonc.2021.12.014. Epub 2022 Jan 10. Ann Oncol. 2022. PMID: 35026411 Free PMC article. Clinical Trial.
Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders.
Kornauth C, Pemovska T, Vladimer GI, Bayer G, Bergmann M, Eder S, Eichner R, Erl M, Esterbauer H, Exner R, Felsleitner-Hauer V, Forte M, Gaiger A, Geissler K, Greinix HT, Gstöttner W, Hacker M, Hartmann BL, Hauswirth AW, Heinemann T, Heintel D, Hoda MA, Hopfinger G, Jaeger U, Kazianka L, Kenner L, Kiesewetter B, Krall N, Krajnik G, Kubicek S, Le T, Lubowitzki S, Mayerhoefer ME, Menschel E, Merkel O, Miura K, Müllauer L, Neumeister P, Noesslinger T, Ocko K, Öhler L, Panny M, Pichler A, Porpaczy E, Prager GW, Raderer M, Ristl R, Ruckser R, Salamon J, Schiefer AI, Schmolke AS, Schwarzinger I, Selzer E, Sillaber C, Skrabs C, Sperr WR, Srndic I, Thalhammer R, Valent P, van der Kouwe E, Vanura K, Vogt S, Waldstein C, Wolf D, Zielinski CC, Zojer N, Simonitsch-Klupp I, Superti-Furga G, Snijder B, Staber PB. Kornauth C, et al. Among authors: zielinski cc. Cancer Discov. 2022 Feb;12(2):372-387. doi: 10.1158/2159-8290.CD-21-0538. Epub 2021 Oct 11. Cancer Discov. 2022. PMID: 34635570 Free PMC article.
How I treat cancer special issue.
Zielinski CC. Zielinski CC. ESMO Open. 2019 May 1;4(Suppl 2):e000514. doi: 10.1136/esmoopen-2019-000514. eCollection 2019. ESMO Open. 2019. PMID: 31231575 Free PMC article. No abstract available.
Triple-negative breast cancer.
Bartsch R, Ziebermayr R, Zielinski CC, Steger GG. Bartsch R, et al. Among authors: zielinski cc. Wien Med Wochenschr. 2010 Apr;160(7-8):174-81. doi: 10.1007/s10354-010-0773-6. Wien Med Wochenschr. 2010. PMID: 20473728 Free article. Review.
CSCO joins ESMO Open-Cancer Horizons.
Zielinski CC, Wu YL. Zielinski CC, et al. ESMO Open. 2016 Nov 18;1(5):e000120. doi: 10.1136/esmoopen-2016-000120. eCollection 2016. ESMO Open. 2016. PMID: 27933216 Free PMC article. No abstract available.
Third CECOG consensus on the systemic treatment of non-small-cell lung cancer.
Brodowicz T, Ciuleanu T, Crawford J, Filipits M, Fischer JR, Georgoulias V, Gridelli C, Hirsch FR, Jassem J, Kosmidis P, Krzakowski M, Manegold C, Pujol JL, Stahel R, Thatcher N, Vansteenkiste J, Minichsdorfer C, Zöchbauer-Müller S, Pirker R, Zielinski CC; Central European Cooperative Oncology Group (CECOG). Brodowicz T, et al. Among authors: zielinski cc. Ann Oncol. 2012 May;23(5):1223-1229. doi: 10.1093/annonc/mdr381. Epub 2011 Sep 22. Ann Oncol. 2012. PMID: 21940784 Free article.
Warfarin for cancer prevention.
Zielinski CC, Hejna M. Zielinski CC, et al. N Engl J Med. 2000 Jun 29;342(26):1991-3. doi: 10.1056/NEJM200006293422612. N Engl J Med. 2000. PMID: 10874070 No abstract available.
Angiogenesis in cancer: Anti-VEGF escape mechanisms.
Prager GW, Poettler M, Unseld M, Zielinski CC. Prager GW, et al. Among authors: zielinski cc. Transl Lung Cancer Res. 2012 Mar;1(1):14-25. doi: 10.3978/j.issn.2218-6751.2011.11.02. Transl Lung Cancer Res. 2012. PMID: 25806151 Free PMC article. Review.
350 results